Dr. Ma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 2007 - 2011
- St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 2006 - 2007
- Washington University in St. Louis School of MedicineClass of 2006
Certifications & Licensure
- MN State Medical License 2011 - 2025
- WI State Medical License 2013 - 2021
- American Board of Radiology Radiation Oncology
Clinical Trials
- Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer Start of enrollment: 2013 Sep 04
- Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC Start of enrollment: 2020 Nov 19
Roles: Contact
Publications & Presentations
PubMed
- 2 citationsCancer in Patients With Incidental Asymmetric Oropharynx Positron Emission Tomography Uptake.Michael F Armstrong, Brian J Burkett, Thomas J O'Byrne, Harrison C Gottlich, Linda X Yin
JAMA Otolaryngology-- Head & Neck Surgery. 2024-12-01 - Accurate patient alignment without unnecessary imaging using patient-specific 3D CT images synthesized from 2D kV images.Yuzhen Ding, Jason M Holmes, Hongying Feng, Baoxin Li, Lisa A McGee
Communications Medicine. 2024-11-21 - Integrative analysis of H&E and IHC identifies prognostic immune subtypes in HPV related oropharyngeal cancer.Sumanth Reddy Nakkireddy, Inyeop Jang, Minji Kim, Linda X Yin, Michael Rivera
Communications Medicine. 2024-10-03
Authored Content
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- Join now to see all
Press Mentions
- Mayo Clinic Q&A Podcast: Head and Neck Cancers Are Becoming Increasingly CommonApril 19th, 2021
- Mayo Clinic Researchers to Present Findings at ASTRO Annual MeetingSeptember 18th, 2019
- Dose De-Escalation in Adjuvant Chemoradiotherapy for HPV-Associated Oropharyngeal Squamous Cell CarcinomaJune 19th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: